Print

HVTN 084

A Randomized, Double Blind Phase 1b Trial to Examine the Influence of Antigenic Competition on the Immunogenicity of HIV-1 Gag/Pol: A Comparison of rAd5 Gag/Pol Env A/B/C to rAd5 Gag/Pol

Trial Details:

I Ongoing
National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network (HVTN) January 20, 2011
VRC-HIVADV014-00-VP,VRC-HIVADV054-00-VP Ad5 env A, env B, env C, gag B, pol B; Ad5 Gag-Pol clade B
VRC-HIVADV054-00-VP Viral Vector - Adeno
VRC-HIVADV014-00-VP Viral Vector - Adeno
Peru, Brazil, USA, Swaziland 100
NCT01159990
http://clinicaltrials.gov/ct2/show/NCT01159990?term=hiv+vaccine&lup_s=07%2F04%2F2010&lup_d=30